QA Connect Management Consulting Announces its Partnership with AmpleLogic
QA Connect Management Consulting is delighted to announce its recent partnership with AmpleLogic, one of the finest GMP Automation brands in
"I am very excited about this collaboration, which will allow QA Connect to expand into the international market for software solutions for the life sciences and medical device arenas and expand our services," stated
Medical devices are used by healthcare professionals and patients to treat and diagnose various conditions such as cancer, Covid-19, and the presence of drugs in urine. These devices include stents and catheters, Covid-19 diagnostic tests, cancer detection kits, urine tests, and intubation bladder and ENT (ear, nose, throat) devices. Software solutions are very a critical component for performance management that meets the stringent needs of the medical device and pharmaceutical industries for regulatory compliance and reducing risk. These software solutions help strengthen and streamline the manufacturing processes for continuous improvement.
In addition to the broader audits, QA Connect Management Consulting, LLC, also provides other services such quality and laboratory validation, QMS setups, EU-MDR 2017/745-746 gap assessments, and backlog quality engineering projects such as a CAPA, supplier, and complaint and recall remediations. The company also does specialized Kaizen process audits for the manufacturing of Class II and Class III medicals devices.
Established in 2020, QA Connect Management Consulting, LLC, is headquartered in
Media Contact:
510-444-9786
[email protected]
View original content:https://www.prnewswire.com/news-releases/qa-connect-management-consulting-announces-its-partnership-with-amplelogic-302049566.html
SOURCE QA Connect Management Consulting, LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bugatti Showcases Steve Dimopoulos' One-of-One Chiron at Pebble Beach Automotive Week
- Hong Kong Specialist Antonelli Expands Lab-Grown Diamond Selection to Over 10,000 Certified Stones
- Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share